This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Touboul P et al. (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24: 1481–1487
White CM et al. (2004) Cardiac Arrhythmias. In Applied Therapeutics: The Clinical Use of Drugs, edn 8, 20.1–20.33 (Eds Koda-Kimble MA. et al.) New York: Lippincott Williams & Wilkins
European Medicines Agency (online 21 September 2006) Questions and answers on the withdrawal of the marketing application for MULTAQ (dronedarone) [www.emea.eu.int/humandocs/PDFs/EPAR/multaq/361489en.pdf] (accessed 2 November 2007)
Dale KM and White CM (2007) Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother 41: 599–605
Roy D et al. (2000) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 342: 913–920
Acknowledgements
The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
White, C. Is dronedarone effective for the prevention of recurrent atrial fibrillation?. Nat Rev Cardiol 5, 136–137 (2008). https://doi.org/10.1038/ncpcardio1089
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1089